Staphylococcus aureus (MRSA) Reduction

Authors

Travis R. Farley, Study Director

Facility

Microbac Laboratories, Inc.

Download
Full Report

Objective

To evaluate the efficacy of the NV900 on reducing methicillin-resistant Staphylococcus aureus (MRSA).

Methodology

The challenge bacteria were aerosolized using a six-jet collision nebulizer under high pressure air and introduced into the chamber with the NV900.

Summary of Results

The NV900 reduced 99.99% of Staphylococcus aureus bacteria over the course of four hours.

MRSA_Reduction_Graph.jpg

CONTACT US

USA Headquarters
35 Melrose Place  Stamford, CT 06902
Call: 1.866.1118  Email: info@wellairsolutions.com

Ireland Headquarters
DCU Innovation Campus Old Finglas Road Glasnevin, Dublin 11
Call: +353 1 907 2750  Email: info@wellairsolutions.com

Social